Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials

[1]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[2]  R. Reiter,et al.  Melatonin protects against lipid peroxidation induced by δ-aminolevulinic acid in rat cerebellum, cortex and hippocampus , 1997, Neuroscience.

[3]  C. Soto,et al.  Inhibition of Alzheimer β-Fibrillogenesis by Melatonin* , 1998, The Journal of Biological Chemistry.

[4]  S. Tufik,et al.  Randomized, double‐blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment , 2000, Journal of pineal research.

[5]  K. Ashe,et al.  Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease , 2000, The Journal of Neuroscience.

[6]  X. Zhu,et al.  Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease , 2001, Neuroreport.

[7]  Virginia M. Y. Lee,et al.  Increased Lipid Peroxidation Precedes Amyloid Plaque Formation in an Animal Model of Alzheimer Amyloidosis , 2001, The Journal of Neuroscience.

[8]  J. Nelson,et al.  Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway , 2001, Brain Research.

[9]  J. Taylor,et al.  Melatonin treatment for age-related insomnia. , 2001, The Journal of clinical endocrinology and metabolism.

[10]  B Frangione,et al.  Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Abeta peptide. , 2001, Biochemistry.

[11]  C. Hess,et al.  Melatonin protects SHSY5Y neuroblastoma cells from cobalt‐induced oxidative stress, neurotoxicity and increased β‐amyloid secretion , 2001, Journal of pineal research.

[12]  M. Grundman,et al.  Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.

[13]  J. Muñoz-Castañeda,et al.  Comparison of melatonin versus vitamin C on oxidative stress and antioxidant enzyme activity in Alzheimer's disease induced by okadaic acid in neuroblastoma cells. , 2002, European journal of pharmacology.

[14]  T. Montine,et al.  Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease , 2003, Journal of Neuroimmunology.

[15]  Koji Abe,et al.  Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease , 2003, Journal of neurochemistry.

[16]  C. Ray.  Melatonin attenuates the sympathetic nerve responses to orthostatic stress in humans , 2003, The Journal of physiology.

[17]  Debomoy K Lahiri,et al.  Dietary supplementation with melatonin reduces levels of amyloid beta‐peptides in the murine cerebral cortex , 2004, Journal of pineal research.